Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies

Phase 3 ◽

Asian Patients ◽

Three Phase ◽

Subgroup Analyses ◽

Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies

Intestinal Research ◽

10.5217/ir.2018.16.2.233 ◽

2018 ◽

Vol 16 (2) ◽

pp. 233 ◽

Cited By ~ 11

Author(s):

Satoshi Motoya ◽

Mamoru Watanabe ◽

Hyo Jong Kim ◽

Young Ho Kim ◽

Dong Soo Han ◽

...

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

East Asian ◽

Phase 3 ◽

Asian Patients ◽

Three Phase ◽

Subgroup Analyses ◽

Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)

Intestinal Research ◽

10.5217/ir.2020.00080 ◽

2020 ◽

Author(s):

Tadakazu Hisamatsu ◽

Hyo Jong Kim ◽

Satoshi Motoya ◽

Yasuo Suzuki ◽

Yoshifumi Ohnishi ◽

...

Keyword(s):

Ulcerative Colitis ◽

East Asian ◽

Efficacy And Safety ◽

Phase 3 ◽

Asian Patients ◽

Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX study

Blood Cancer Journal ◽

10.1038/s41408-018-0071-x ◽

2018 ◽

Vol 8 (4) ◽

Cited By ~ 14

Author(s):

Kenshi Suzuki ◽

Meletios A. Dimopoulos ◽

Naoki Takezako ◽

Shinichiro Okamoto ◽

Atsushi Shinagawa ◽

...

Keyword(s):

Multiple Myeloma ◽

East Asian ◽

Phase 3 ◽

Refractory Multiple Myeloma ◽

Asian Patients ◽

Subgroup Analyses ◽

First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial

European Journal of Cancer ◽

10.1016/j.ejca.2014.05.011 ◽

2014 ◽

Vol 50 (13) ◽

pp. 2219-2230 ◽

Cited By ~ 23

Author(s):

James Chih-Hsin Yang ◽

Jin Hyoung Kang ◽

Tony Mok ◽

Myung-Ju Ahn ◽

Vichien Srimuninnimit ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

East Asian ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Phase 3 ◽

Asian Patients ◽

Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis

Gastroenterology ◽

10.1016/s0016-5085(18)31575-0 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-380-S-381

Author(s):

Mamoru Watanabe ◽

Satoshi Motoya ◽

Kenji Watanabe ◽

Haruhiko Ogata ◽

Takanori Kanai ◽

...

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Japanese Patients ◽

Phase 3

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-Maintenance

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01665 ◽

2012 ◽

Vol 107 ◽

pp. S673-S674

Author(s):

William Sandborn ◽

Brian Feagan ◽

Colleen Marano ◽

Richard Strauss ◽

Jewel Johanns ◽

...

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy

Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study)

Journal of Gastroenterology ◽

10.1007/s00535-017-1326-1 ◽

2017 ◽

Vol 52 (10) ◽

pp. 1101-1111 ◽

Cited By ~ 20

Author(s):

Toshifumi Hibi ◽

Yuya Imai ◽

Asako Senoo ◽

Kentaro Ohta ◽

Yoshifumi Ukyo

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind

P0066 A randomised phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib as maintenance with gefitinib monotherapy in east Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer

European Journal of Cancer ◽

10.1016/j.ejca.2014.03.110 ◽

2014 ◽

Vol 50 ◽

pp. e27 ◽

Cited By ~ 1

Author(s):

J.C-H. Yang ◽

K. Park ◽

T. Mok ◽

J.H. Kang ◽

V. Srimuninnimit ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

East Asian ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Phase 3 ◽

Asian Patients ◽

Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin (PCC) in East Asian patients (pts) with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.9058 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 9058-9058 ◽

Cited By ~ 5

Author(s):

Shun Lu ◽

Tony Mok ◽

You Lu ◽

Jianying Zhou ◽

Yuankai Shi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

East Asian ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Phase 3 ◽

Asian Patients ◽

P838 Complicated disease in East Asian patients with ulcerative colitis over two decades: A single-centre retrospective cohort in Japan

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.965 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S539-S540

Author(s):

T Taida ◽

J Kumagai ◽

S Ogasawara ◽

Y Ohta ◽

S Hamanaka ◽

...

Keyword(s):

Ulcerative Colitis ◽

Retrospective Cohort ◽

East Asian ◽

Single Centre ◽

Asian Patients ◽